Sinovac Biotech (北京科兴生物制品有限公司) has begun producing an influenza A (H1N1) pandemic vaccine. The company today received virus seed from US Centers for Disease Control. The company is aiming at delivering a vaccine as soon as October. To increase its production capacity in this emergent situation, Sinovac is collaborating with other China vaccine companies to produce supplies Panflu, its pandemic vaccine, with H1N1 virus seed. More details...

Stock Symbol: (NYSE Amex: SVA)